1. Home
  2. ABVX vs QBTS Comparison

ABVX vs QBTS Comparison

Compare ABVX & QBTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • QBTS
  • Stock Information
  • Founded
  • ABVX 2013
  • QBTS 1999
  • Country
  • ABVX France
  • QBTS United States
  • Employees
  • ABVX N/A
  • QBTS N/A
  • Industry
  • ABVX
  • QBTS Retail: Computer Software & Peripheral Equipment
  • Sector
  • ABVX
  • QBTS Technology
  • Exchange
  • ABVX Nasdaq
  • QBTS Nasdaq
  • Market Cap
  • ABVX 5.3B
  • QBTS 5.9B
  • IPO Year
  • ABVX N/A
  • QBTS N/A
  • Fundamental
  • Price
  • ABVX $83.31
  • QBTS $24.01
  • Analyst Decision
  • ABVX Strong Buy
  • QBTS Strong Buy
  • Analyst Count
  • ABVX 8
  • QBTS 10
  • Target Price
  • ABVX $90.63
  • QBTS $19.40
  • AVG Volume (30 Days)
  • ABVX 1.1M
  • QBTS 38.2M
  • Earning Date
  • ABVX 08-11-2025
  • QBTS 11-13-2025
  • Dividend Yield
  • ABVX N/A
  • QBTS N/A
  • EPS Growth
  • ABVX N/A
  • QBTS N/A
  • EPS
  • ABVX N/A
  • QBTS N/A
  • Revenue
  • ABVX $7,073,400.00
  • QBTS $22,275,000.00
  • Revenue This Year
  • ABVX $25.23
  • QBTS $182.64
  • Revenue Next Year
  • ABVX N/A
  • QBTS $52.50
  • P/E Ratio
  • ABVX N/A
  • QBTS N/A
  • Revenue Growth
  • ABVX N/A
  • QBTS 120.20
  • 52 Week Low
  • ABVX $4.77
  • QBTS $0.87
  • 52 Week High
  • ABVX $92.91
  • QBTS $24.85
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 61.47
  • QBTS 81.50
  • Support Level
  • ABVX $82.72
  • QBTS $14.88
  • Resistance Level
  • ABVX $86.72
  • QBTS $15.96
  • Average True Range (ATR)
  • ABVX 3.94
  • QBTS 1.27
  • MACD
  • ABVX -1.81
  • QBTS 0.90
  • Stochastic Oscillator
  • ABVX 25.93
  • QBTS 91.66

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.

Share on Social Networks: